Search results
Showing 136 to 150 of 303 results for breast cancer
delivery, number of sessions) to reduce arm and shoulder problems after breast cancer surgery or radiotherapy, and what is the...
In development [GID-TA11400] Expected publication date: TBC
Ocrelizumab for treating relapsing–remitting multiple sclerosis (TA533)
Evidence-based recommendations on ocrelizumab (Ocrevus) for treating relapsing–remitting multiple sclerosis in adults.
Evidence-based recommendations on dabrafenib (Tafinlar) with trametinib (Mekinist) for resected stage III, BRAF V600 mutation-positive melanoma in adults.
In development [GID-TA10326] Expected publication date: TBC
Awaiting development [GID-TA11403] Expected publication date: TBC
In development [GID-TA11402] Expected publication date: TBC
Awaiting development [GID-TA11165] Expected publication date: TBC
for neoadjuvant endocrine therapy in postmenopausal women with early breast cancer? Any explanatory notes(if applicable) To find out why...
Awaiting development [GID-TA10896] Expected publication date: TBC
Awaiting development [GID-TA11342] Expected publication date: TBC
Awaiting development [GID-TA11273] Expected publication date: TBC
Awaiting development [GID-TA11487] Expected publication date: TBC
Everolimus for advanced renal cell carcinoma after previous treatment (TA432)
Evidence-based recommendations on everolimus (Afinitor) for advanced renal cell carcinoma after previous treatment.